The origin of the idea of the Earth being spherical-as opposed to a flat structure-is credited to Pythagoras around 500 bc. However, it was not until around 350 bc that Aristotle made physical observations to support such a claim. Despite the astonishing precision achieved by Eratosthenes of Cyrene in determining the circumference of the Earth (ca. 240 bc), it was not until Portuguese explorer Ferdinand Magellan circumnavigated the Earth between 1519 and 1522 that such estimation was widely accepted ("This Month in Physics History," June 2006 [Vol 5, Number 6] . APS News. Retrieved from https:// www.aps.org/publications/apsnews/200606/history.cfm. Accessed on September 9, 2019).
Ancient Greeks used ingenuity and available methods of the time to answer questions that affected civilization for centuries. Fortunately, curiosity and skepticism has often moved scientific discovery by challenging established paradigms, resulting in a new "truth" at a specific time. In a much shorter span of time, but in an analogous fashion, anesthesiology has evolved from the first demonstrations of surgical anesthesia in the 19th century to its contemporary form. Who would have thought development of our specialty will affect the practice of medicine in such way? Similar to the ancient Greeks, many challenges have been overcome in anesthesiology, and the paradigm of our understanding of physiology and pharmacology have evolved. Despite such progress, during recent decades global changes in many other aspects have also evolved, even forcing us to question the future of our practice. Our specialty in general, and cardiothoracic and vascular anesthesiology in particular, are young and versatile fields that have embraced challenges as fuel for its progress. 1 The development of research and improved practice patterns will continue to nurture our growth into the future. 2, 3 With that premise in mind, Seminars in Cardiothoracic and Vascular Anesthesia (SCVA), for the first time, includes abstracts of a scientific meeting as a reflection of developing ideas and evolving approaches to patient care. This issue of SCVA opens with an overview of abstracts presented at the 2019 Congenital Cardiac Anesthesia Society Annual Meeting. Dr Latham provides an excellent description of the abstract session and highlighted themes, including a concise review of selected oral presentations. His description of the abstract session is further accompanied by his highly informative podcast, which can be viewed at https://journals.sagepub.com/home/scv.
The diversity of sources and nature of articles presented in this issue of SCVA are encouraging. Collectively, they represent ingenuity and adaptability in the face of a changing perioperative environment. Whether in the form of original research, description of institutional experience, or review of available evidence, they all shift accepted paradigms of intraoperative care and help establish new truths in our understanding of patient care. Such works are pushing the boundaries of anesthesia practice beyond the operating room while embracing the new paradigm of integrated perioperative care.
The Cardiac Review section of the present issue includes a comprehensive, yet concise and very useful review of available evidence regarding periprocedural management of oral anticoagulants for nonoperating room settings written by Drs Tao and Oprea. 4 Almost certainly, the most significant change in the practice of anesthesiology is expansion of nonoperating room procedures. Given the increased trend toward less invasive interventions and more complex diagnostic procedures, it is projected that within the next 10 years, more than 50% of procedures involving anesthesiology care will be performed in nonoperating room settings. 5 The highly relevant article by Tao and colleague further contributes to the evidence of the importance of anesthesia care providers to add value to multidisciplinary care teams managing novel anticoagulant medications outside the operating room.
The second contribution to the Cardiac Review section, written by Hillenbrand and colleagues, explores difficult transesophageal echocardiogram (TEE) probe placement. 6 The article discusses up-to-date information about possible mechanisms and risk factors for difficult TEE probe placement, including absolute and relative contraindications to TEE probe placement. The authors propose an interesting algorithmic approach to this problem and describe advantages and disadvantages of several alternative options. One of the most important paradigms shift in the practice of cardiothoracic anesthesia in recent decades came from the introduction of TEE as an essential dynamic intraoperative monitoring and diagnostic tool during most cardiac surgical and interventional procedures. 7 The role of the anesthesiologist in the cardiac operating room has evolved into an active participant and advisor in decision making with well-demonstrated impact on short-and longterm outcomes. 7 Incorporation of alternative techniquesrelevant in this setting, into our practice would increase the armamentarium at our disposal, thus enhancing the positive influence of our involvement in the perioperative team.
In this issue of SCVA, the Congenital Cardiac Forum contains 3 excellent articles in addition to Dr Latham's review of the Congenital Cardiac Anesthesia Society Scientific Meeting abstracts. The first article, "Preoperative Physiology, Imaging, and Management of Coarctation of Aorta in Children" by Ganigara and colleagues, contains excellent images from echocardiography, computed tomography, magnetic resonance imaging, and the cardiac catheterization laboratory. 8 Coarctation of the aorta is a deceptively simple obstructive lesion of the aortic arch, with considerable variation in clinical presentation, anatomy, and physiology. This excellent review describes the differences in presentation and how various imaging modalities help guide initial management and the unfortunate problem of recurrence of the coarctation. This article accompanies an earlier publication in SCVA by Fox and colleagues, which focuses on the perioperative anesthetic management of this lesion. 9 Together, both articles provide a comprehensive guide to the management of this common congenital heart lesion. The second article in the Congenital Cardiac Forum, "Deep Tracheal Extubation Using Dexmedetomidine in Children with Congenital Heart Disease Undergoing Cardiac Catheterization: Advantages and Complications" by Gautam and colleagues, is an original research article. 10 One of the problems unique to young children following cardiac catheterization is the challenge of having them lay flat and still to prevent rebleeding and hematoma formation at the femoral access sites. The solution to this problem requires a paradigm shift in our traditional approach to waking a patient up following general anesthesia. The pediatric anesthesiologist has to find the fine line between having a spontaneously breathing patient with a safe airway who is still asleep and the awake young patient moving around the bed. Gautam and colleagues studied how a combination of deep tracheal extubation and the use of dexmedetomidine during the cardiac catheterization procedure was safe in young children in the recovery period. This attests to the skill of their pediatric anesthesia team and how we use anesthetic drugs to the patient's advantage for the intraoperative and postoperative periods. The final article in the Congenital Cardiac Forum, "Anesthesia for Pediatric Heart Transplantation: Are Patients with a Failing Hemi-Fontan-or Fontan Physiology Different?" by Mueller and colleagues, is an original research study from Germany. 11 The study investigators compared cardiac transplantation in patients with failed Fontan circulation to patients undergoing cardiac transplantation for cardiomyopathy and congenital heart disease (CHD). The authors report data from a 10-year period during which 83 cardiac transplants were performed. They found that cardiac transplantation in the failing Fontan circulation group was much more challenging compared with the cardiomyopathy/CHD group. The failing Fontan group had longer surgical times, longer donor organ ischemia times, and required more vasoactive/inotropic support after separation from cardiopulmonary bypass. The differences persisted after bypass with the failing Fontan group requiring more blood products and coagulation factor concentrates. Unfortunately, the failing Fontan physiology patients had almost 4 times the 90-day mortality compared with the transplanted cardiomyopathy/CHD group. This study reflects that although each group of patients received a new heart, the underlying recipient patient physiology affects eventual outcomes. Single ventricle physiology is complex and staged palliation to the Fontan circulation affects other organs, including the lungs and liver. While the outcomes of these staged palliative surgeries are very good, with many children surviving into adulthood, we are now being challenged by problems that were unknown until now. Such problems include liver disease, which often necessitates combined heart-liver transplantation in adults with failed Fontan circulation. While some of these liver complications may be mitigated by earlier cardiac transplantation alone, these transplants are higher risk as shown by Mueller and colleagues, and there remains a shortage of donor organs. One of the greatest challenges in the field of CHD will be the paradigm shift that will need to occur in the future management of patients with single ventricle physiology.
In the Transplant Forum section of this issue, the fellowship committee of the Society for Advancement of Transplant Anesthesiology in conjunction with their designated liver transplant anesthesiology fellowship task force propose comprehensive recommendations for competencies and milestones desirable in trainees enrolled in any liver transplant anesthesiology fellowship. 12 This subspecialized area of transplant anesthesiology has rapidly evolved into a separate practice within our specialty. Since 2011, a major paradigm shift occurred when the Organ Procurement and Transplantation Network/United Network for Organ Sharing started requiring liver transplantation centers to have dedicated liver transplant anesthesia teams and divisions. 13 Nonetheless, there are no uniform training requirements for existing liver transplantation anesthesiology fellowships. The article provides a consensus-based document of expert opinion toward the goal of uniform training requirements. Over and above a continued debate regarding the suitability of general anesthesia teams as opposed to dedicated liver transplant anesthesia teams-to provide the best care for such complex patients-there is a continued trend toward subspecialization in this and other areas within anesthesiology. 14 In addition, it is increasingly difficult to provide enough experience in liver transplantation to anesthesiology residents in all programs. Sufficient training experience may be possible at large academic and transplantation referral institutions but not at smaller programs. 15 Furthermore, in solid organ transplantation, there is increasing evidence for improved outcomes in high-volume programs, when compared with low-volume institutions. For example, by analyzing large high-risk liver transplantation data, Ozhathil and colleagues showed that high-volume centers demonstrated lower risk of allograft failure and recipient death. 16 Similarly, Weiss and colleagues demonstrated that higher volume lung transplantation centers have decreased risk of 30-day, 1-year, and 5-year recipient mortality. 17 Likewise, center volume and expertise has been associated with improved survival after cardiac transplantation and mechanical circulatory support. 18, 19 Such information substantiates the contemporary tendency toward regionalization or centralization of care involving complex patients who undergo high-cost and resource-intensive interventions, as a strategy to improve outcomes and increase cost-effectiveness. 20 This current paradigm shift is reflected in the increased need for subspecialization of the practice of anesthesia, and the standardization of training objectives, with the ultimate goal of improving patient outcomes amidst a changing landscape based on multidisciplinary practice.
The second contribution to the Transplant Forum by Crouch and colleagues describes a case of an uncommon complication secondary to the use of hydroxocobalamin for the treatment of refractory vasoplegic syndrome. 21 Hydroxocobalamin-induced plasma discoloration is known to interfere with the function of hemodialysis machines inadvertently triggering an automatic shutdown due to a false "blood leak" alarm. 22 In the presented scenario, a patient undergoing combined liver-kidney transplant had recurrent hemodialysis machine stoppage even after exchange to a new machine. This resulted in worsening acid-base status of the patient and a delay in kidney allograft transplantation with consequent increase in kidney graft ischemic time. Although successful management of vasoplegic syndrome with hydroxocobalamin during liver transplantation has been previously reported, 22 this is the first known report of this particular complication in this setting. Given the high incidence of vasoplegic syndrome (up to 40%) and its association with decreased survival in multiple settings, including transplantation and cardiac surgery, there is active research into the pathophysiology of this syndrome. 23 The Clinical Challenges section of this issue presents 2 reports. The first one by Mocavero and colleagues, is a thought-provoking description of the management of a patient with severe functional mitral regurgitation with a MitraClip. 24 This report describes the well-planned, physiologically oriented, and aggressive management led by the anesthesiology team, which allowed successful device implantation in a patient otherwise deemed ineligible for a MitraClip according to accepted inclusion criteria. This case is an example of comprehensive anesthesiology management integrated into the multidisciplinary procedural team. Not only did this team demonstrate sound hemodynamic management but also active participation in multimodal monitoring and active decision making, thus pushing the boundaries of prevailing paradigms of intraoperative care. In a similar fashion, the second report by Abrams and colleagues describes the intraoperative diagnosis of an inferior vena cava to right atrial anastomotic site obstruction after orthotopic heart transplantation with bi-caval technique. 25 Although superior or inferior caval anastomosis stenosis is not a frequent complication, in this case the anastomotic obstruction was caused by the presence of a large Eustachian valve from the native heart. The significance of this case is the proactive use of a comprehensive TEE examination, leading to early detection of an unsuspected complication. In addition, hemodynamic monitoring was used to confirm the pressure gradient at the anastomotic site. Certainty about the diagnosis prompted return to cardiopulmonary bypass for immediate correction. This report demonstrates the leading role of the cardiac anesthesiologist integrated into the surgical team, and how collaborative decision-making and excellent teamwork within the perioperative environment improves patient outcomes.
This issue of SCVA presents examples of the increased involvement of our subspecialty at different levels of perioperative care looking to ultimately resolve evolving problems in an increasingly complex patient population. The role of the cardiothoracic and abdominal organ transplant anesthesiologists will continue to develop along with the increased demands posed by new, less invasive but more complex procedures and emerging technologies. These along with a shifting contemporary practice involving more nonoperating room patient care, will continue to challenge our adaptability and the versatile nature of our specialty. We need to be prepared and keep providing the safest and highest quality evidence-based care within the context of the ever-changing landscape of the cardiovascular and abdominal organ transplant medicine worlds.
